Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of High Dose Lenalidomide in Patients With Refractory/Relapsed Acute Leukemia as a Bridge to Bone Marrow Transplant

NCT01615042 is registered in ClinicalTrials.gov with Mehrdad Abedi, MD as lead sponsor.

NCT NCT01615042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01615042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of High Dose Lenalidomide in Patients With Refractory/Relapsed Acute Leukemia as a Bridge to Bone Marrow Transplant
Lead sponsor
Mehrdad Abedi, MD
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2012
Completion date
May 31, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia